Register people with myotubular or centronuclear myopathy
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study sets up a patient registry for people diagnosed with myotubular myopathy or centronuclear myopathy. Your information can help researchers better understand these conditions and plan future studies or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of myotubular myopathy or centronuclear myopathy
- That diagnosis was confirmed with genetic testing or a muscle biopsy
- If you are a female carrier of x-linked myotubular myopathy, you may still qualify
- If you have symptoms of myotubular myopathy as a carrier, that can count
- If you are deceased, the study may include you if the diagnosis was confirmed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks at genes and molecules to better understand congenital myopathies (birth-related muscle weakness). It may help explain the cause of symptoms and improve future diagnoses for you and your family.
This study looks at people with RYR1-related conditions like muscle weakness or malignant hyperthermia. The goal is to learn more about these conditions and how common they are.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This is a national registry that collects information from people who have (or may soon have) myotonic dystrophy. By joining, you help researchers better understand the disease and may make future studies easier to access.
This study builds a registry of people and families affected by myotonic dystrophy types 1 and 2. It helps researchers learn about the condition over time and may support future studies that could lead to better care.
This is a registry study that collects health information from people with myotonic dystrophy (a genetic muscle disease that causes weakness and stiffness) or facioscapulohumeral muscular dystrophy (a genetic condition affecting shoulder and face muscles), as well as their unaffected family members. The information helps researchers better understand these conditions and track how they progress over time.
Hear when a new Centronuclear Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.